Skip to main content

Table 3 The comparison of clinical variables in different CKD stages

From: Association between fibrosis-related gene polymorphism and long-term allograft outcome in renal transplant recipients

Clinical variables

CKD1

CKD2-3

CKD4-5

P

BUN(mmol/L,mean ± SD)

5.71 ± 1.50

8.46 ± 3.53

25.29 ± 10.82

 > 0.001

Scr(umol/L,mean ± SD)

81.16 ± 13.79

132.73 ± 34.41

423.69 ± 113.16

 > 0.001

Upro,n(%)

   

 > 0.001

 -

57

49

1

 

  + 

4

12

6

 

  +  + 

1

5

4

 

  +  +  + 

0

1

1

 

  +  +  +  + 

0

1

1

 

eGFR(ml/min/1.73m2,mean ± SD)

124.75 ± 26.69

65.49 ± 14.84

18.16 ± 6.68

 > 0.001

Age(years, mean ± SD)

34.45 ± 9.328

38.01 ± 9.40

42.38 ± 10.47

0.01

Weight (kg,mean ± SD)

61.71 ± 9.39

59.10 ± 7.99

59.88 ± 7.31

0.107

Gender,n(%)

   

0.009

 Male

55

41

9

 

 Female

7

27

4

 

Duration after renal transplant(days, mean ± SD)

2661.53 ± 406.45

2711.21 ± 499.79

2770.92 ± 521.74

0.686

Incidence of DGF episodes, n (%)

26

21

4

0.391

Incidence of AR episodes, n (%)

22

27

5

0.883

Usage of RAPA, n (%)

8

8

1

0.869

ISD protocol,n(%)

   

0.634

 CsA

26

23

5

 

 FK506

36

45

8